Difference between revisions of "Vitronectin (TG2)"
m |
m |
||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
! {{infobox header}}| '''{{PAGENAME}}''' | ! {{infobox header}}| '''{{PAGENAME}}''' | ||
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
Revision as of 08:40, 4 January 2008
| Template:Infobox header| Vitronectin (TG2) | |
|---|---|
| Substrate peptide name | Vitronectin |
| Synonyms | Serum-spreading factor |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Cytoskeleton |
| Swissprot ID | P04004 |
| Reactive glutamines | Q93* |
| Reactive lysines | - |
| Substrate sequence | KGNPEQTPVLK |
| Structure | 1OC0 |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:2461707 |
| Notes | *Reactive Q residues have been determined only for FXIIIa catalyzis; probably TG2 uses the same Q residues as substrates |
| Template:Infobox header | |
